Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02614066 |
|---|---|
| Brief Title: | A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3) (ZUMA-3) |
| First Submitted : | November 23, 2015 |
| First Submitted that Met QC Criteria : | November 24, 2015 |
| First Posted : | November 25, 2015 (Estimate) |
| Results First Submitted : | September 9, 2021 |
| Results First Submitted that Met QC Criteria : | October 29, 2021 |
| Results First Posted : | November 29, 2021 |
| Last Update Submitted that Met QC Criteria : | November 14, 2023 |
| Last Update Posted : | November 18, 2023 |